ArticlemedRxiv : the preprint server for health sciences2024

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.

Ryan J Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.